ONLINE EVENT: You can participate Virtually from your home or work.
Dhuha Al Sajee, Speaker at Cancer Conferences
St Joseph’s Healthcare Hamilton, Canada

Abstract:

Malignant tumors of the sinonasal tract account for approximately 3% of all head and neck malignancies. These tumors typically carry a poor prognosis. Diagnosis can be particularly challenging due to the small size of biopsy samples, crush artifact, and overlapping histologic and clinical features. A broad general approach that includes detailed clinical and radiological review, correlation of the histological features with immunohistochemical findings and the appropriate use of molecular studies help reach a correct diagnosis.

While squamous cell carcinoma (SCC) represents the majority of sinonasal malignancies, a growing number of recently characterized entities also demonstrate squamous differentiation but are not true SCCs. Examples such as NUT carcinoma, teratocarcinosarcoma, and SWI-SNF complex deficient carcinomas among others warrant accurate diagnosis. Accurate recognition of these distinct tumor types is crucial, as their clinical behavior, treatment strategies, and prognoses may differ significantly from conventional SCC.

Biography:

Dr. Dhuha Al-Sajee graduated from Al-Nahrain University, college of Medicine in 2000. She pursued a career in pathology by obtaining an MSc in histopathology 2005 (Al-Nahrain University, Baghdad, Iraq), then the certificate of the Arab Board for Health Specialization in 2014. She then joined McMaster University in 2011 and obtained a Ph.D and postdoctoral fellowship (2018) and eventually completed a residency training in Anatomical pathology in 2023. She later joined the University Health Network/Toronto General Hospital as a clinical fellow to subspecialize in Head and Neck Pathology and competed this fellowship in 2024. Currently, she is a head and neck pathologist at St. Joseph’s Healthcare Hamilton, On, Canada.

Watsapp
a